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Edited by Varda RotterAbstract We have used surface plasmon resonance to quantify
the kinetics and stoichiometry of the interaction between p53 and
nucleophosmin (NPM). Domains characterising the interface be-
tween the two proteins were identiﬁed by chemical cross-linking,
proteolytic digestion and mass spectrometry based peptide map-
ping.We show that the C-terminal domain of NPM (residues
242–269) interacts with two regions of p53 (residues 175–196
and residues 343–363) which belong, respectively, to the DNA
binding domain and the tetramerisation domain. Potential bio-
logical consequences of such interactions are discussed.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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NPM/B23 (nucleophosmin) is one of the most abundant
phosphorylated proteins in the nucleolus. A characteristic of
this protein is that it is more abundant in proliferating cells
whether they are normal or not. Its role during proliferation
was originally believed to be restricted to ribosome maturation
[1,2]. In fact, NPM is a multifunctional protein; it binds to pRb
and synergistically stimulates DNA polymerase a [3] and also
binds to the centrosome inhibiting duplication [4]. Nucleo-
phosmin is furthermore involved in several transcription pro-
cesses through its interaction with transcription factors and
its histone chaperone activity [5–7]. NPM is induced after
genotoxic stress where it allows cells to resist DNA damage
either by increasing their DNA repair capacity or by decreas-
ing the apoptotic signal [8–11]. These functions have been fur-
ther related to the capacity of NPM to stabilise or inhibit p53
[12–14]. Cellular determinants regulating such opposite eﬀects
are not well understood. An important factor seems to be the
level of NPM expression. NPM could interact diﬀerently with
the p53-MDM2-ARF pathway according to its level of expres-Abbreviations: ACN, aceto-nitrile; EDC, N-ethyl-N 0-(3-dimethylami-
nopropyl) carbodiimide; GST, glutathione transferase; NHS, N-hyd-
roxysuccinimide; NPM, nucleophosmin; NES, nuclear export signal;
SELDI, surface-enhanced laser desorption and ionisation; SPR, surf-
ace plasmon resonance; TFA, triﬂuoroacetic acid
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NPM exerts its eﬀect on p53 stabilisation or inhibition through
its interaction with ARF [15]. However at high levels, NPM
can stabilise p53 even in an ARF/ cell line thus suggesting
a direct interaction. In this context, there are two questions
that should be addressed ﬁrst, what domains of p53 and
NPM contribute to the interaction, and secondly, what are
the eﬀects of this interaction? In order to answer these ques-
tions, we analysed the kinetic parameters of the NPM and
p53 interaction using surface plasmon resonance (SPR) tech-
nology. In parallel, by combining NPM–p53 chemical cross-
linking to a surface-enhanced laser desorption and ionisation
(SELDI) analysis of cross-linked peptides, we mapped their
interaction domains.2. Material and methods
2.1. Chemicals, enzymes, proteins
Recombinant glutathione transferase (GST) and GST-p53 proteins
in PBS +30% glycerol were a gift of Dr. K. Gaston (Bristol University
UK). Human placenta total RNA (636527) was from BD Biosciences.
AmpliTaq DNA polymerase was from Applied Biosystems. Protein A
was from Calbiochem. Polyclonal antibodies antiNPM (3542) and
antiGST (2622) were from CST. Protease inhibitors cocktail tablets
(EDTA-free) was from Roche Applied Science. HiTRAP chelating
and aﬃnity columns were from Amersham Biosciences. All chemicals
were from VWR or from Sigma and were of analytical grade.
2.2. Plasmid construction
NPM ORF was ampliﬁed using 5 0GACGACAAGCATATG-
GAAGATTCGGATGGACA30 and 5 0GCTCCTCGAGTTAAAG-
AGACTTCCTCCACTGC3 0, respectively, as forward and reverse
primers and cDNA from Human Placenta. The forward primer con-
tains a NdeI site before the translation initiation codon. The reverse
primer contains a XhoI site after the stop codon. The NPM ORF
was inserted between the NdeI and XhoI sites of the pNT1 plasmid
(pET-19b plasmid without the enterokinase binding site).
2.3. Production and puriﬁcation of recombinant His-tagged NPM
BL21 (DE3) bacteria were transformed with pNT1/NPM plasmid
and grown in 1 l of terriﬁc broth at 30 C until an OD600nm of 0.3. Pro-
tein NPM synthesis was induced by addition of 1 mM of IPTG for 3 h.
Cells pellets were suspended in 20 ml of lysis buﬀer at 4 C (Tris
50 mM pH 7.8, NaCl 500 mM, 10% glycerol, antiprotease cocktail).
Bacteria were lyzed using a French press. Bacterial debris were elimi-
nated by centrifugation. NPM protein was puriﬁed using three diﬀer-
ent columns: a heparin sepharose column (HiTRAP Heparin HP)
followed by a puriﬁcation on a nickel chelating column (HiTRAP che-
lating HP) and an anion exchange column Mini Q PC. NPM protein
purity was checked using SDS–PAGE before dialysis against T buﬀer
(Tris 50 mM pH 7.8, 10% glycerol, 1 mM DTT). NPM was concen-
trated to 1–2 mg/ml using centriprep concentrators.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Sensorgram of GST-p53 binding to immobilised NPM.
4.19 · 1015 mole of antiNPM antibody immobilised on a protein A
Biacore surface was used to capture NPM. GST-p53 (1.4 lM) was
ﬂowed across the surface at 20 ll/min. The apparent kd was obtained
by ﬁtting the dissociation phase to the expression R(t) = R(o) exp
(kdÆt)
where (R) is the relative change in resonance response as a function of
time (t). The apparent ka was obtained from RðtÞ ¼
RðmaxÞ ð1 expððka ðCÞ þ kdÞtÞÞ at a given protein concentration of (C)
where R(max) is the response at steady state. The apparent overall
dissociation constant Kd was calculated from the ratio of kd/ka. The
overall dissociation constant (Kd = 3.1 · 107) was calculated from the
ratio of the oﬀ rates (kd = 1.35 · 103 s1) and on rates
(ka = 4.3 · 103 M1 s1) obtained from the ﬁt of the dissociation and
association phases, respectively.
Table 1
346 B. Lambert, M. Buckle / FEBS Letters 580 (2006) 345–3502.4. Binding analysis by SPR
Binding studies were performed using a Biacore 1000 surface plas-
mon resonance instrument (Biacore, Inc.). Protein A (100 lg/ml) in
10 mM Na acetate (pH 5.2) was covalently attached to CM5 sensor
chip surfaces through its amine group [16]. Antibodies (polyclonal
IgG) against NPM were then bound to the immobilised protein A.
Binding of GST-p53 was studied by injecting 60 ll of GST-p53 solu-
tion at various concentrations over immobilised NPM at a ﬂow of
10 ll/min. All experiments were performed at 25 C.
2.5. Cross-linking analysis
GST-p53 (9 lM) was incubated at 4 C for 60 min with NPM at var-
ious ratios of molar concentration in PBS supplemented with 30%
Glycerol. Proteins were then incubated at 25 C for 15 min before
the addition of the cross-linking mixtures (5 mM N-hydroxy-
succinimide (NHS) and 20 mM N-ethyl-N 0-(3-dimethylaminopropyl)
carbodiimide (EDC), ﬁnal concentrations). After 2 min incubation at
25 C the reaction was stopped by adding SDS–PAGE loading buﬀer.
Reaction products were analysed on SDS–PAGE.
2.6. Peptide mapping and SELDI analysis
Non-cross-linked and cross-linked material separated by SDS–
PAGE were visualised by Coomassie staining and excised into Eppen-
dorf tubes. The bands were destained by successive washing with
150 ll aliquots of 50:50 (v/v) aceto-nitrile (ACN): 25 mM NH4CO3
and then dried in a speed vac. Tryptic digestion was carried out by
adding 5 ll of trypsin (Sequencing grade, Promega) solution (0.1 lg/
ll in 1% acetic acid) and 25 ll of 25 mM ammonium bicarbonate
pH 8.0. Gel slices were incubated at 37 C overnight. Peptides were ex-
tracted by the addition of 30 ll of 50:50 (v/v) ACN: H2O, 5% triﬂuo-
roacetic acid (TFA), incubation for 30 min and removal of the
supernatant to a clean Eppendorf tube. This process was repeated
twice and the pooled supernatants were dried to completion before
reconstitution by the addition of 5 ll of a solution of 0.1% TFA 5%
acetonitrile.
Aliquots (1 ll) of peptide solutions were applied to either SEND
or H4 ProteinChip surfaces, 1 ll of an appropriate matrix solution
was added for cocrystallisation and the ProteinChips were analysed
using a SELDI ProteinChip reader. The sequences used for analy-
sis predictions can be retreived in databanks with the following protein
identiﬁcation: p53 (CAA42627), NPM (AAH08495) and GST
(AAA57107). The GST was assumed to make little diﬀerence to the
peptide analysis of p53 apart from at the immediate N-terminal.Binding parameters for GST-p53 binding to immobilised NPM
Concentration (lM) ka (M
1 s1) kd (s
1) Kd (M)
1.4 4.30 · 103 1.35 · 103 3.14 · 107
7.0 2.14 · 103 1.94 · 103 9.06 · 107
7.0 8.31 · 103 2.50 · 103 3.01 · 107
Anti-NPM immobilised to protein A covalently bound to a CM5
Biacore surface was used to ﬁx NPM. GST-p53 at diﬀerent concen-
trations was then ﬂowed across the surface.3. Results and discussion
3.1. SPR analysis of p53 binding to NPM
A GST-p53 fusion protein (1.4 lM) was passed across
immobilised NPM on a BIAcore sensor chip and the ensuing
change in refractive index at the surface measured over time
(Fig. 1). The GST-p53 was retained by the surface. GST alone
did not interact with the immobilised NPM (data not shown).
Dissociation rate constants (kd) obtained from the curve
shown in Fig. 1 gave values of 1.35 · 103 s1. This rate was
then used to calculate the on rate (ka) for the association phase
(ka of 4.3 · 103 M1 s1). The overall dissociation constant
(Kd) is thus 3.1 · 107 M. Table 1 resumes rates obtained from
three separate experiments giving an average Kd of 5.07 ·
107 M calculated from the three Kd values reported in Table
1.
SPR allows relatively accurate measurements of changes in
mass at a surface and this has been empirically calibrated
such that a change of 1000 resonance units (RU) in the bia-
core conﬁguration corresponds to a change in mass of 1 ng
for a globular protein [17]. We could thus ascertain that
0.82 fmoles of GST-p53 were retained by the immobilised
NPM (1.9 fmoles); this corresponds to a monomeric stoichi-
ometry of 0.43:1 for GST-p53:NPM. The antiNPM antibod-ies (directed against the N-terminal domain) were
constrained by a protein A interaction that should allow max-
imum accessibility for the NPM–antiNPM interaction. It ap-
pears that one GST-p53 monomer binds for every two
immobilised NPM monomers.
3.2. SDS–PAGE analysis of cross-linking of NPM to GST-p53
In order to conﬁrm the interaction between p53 and NPM
we carried out carbodiimide mediated cross-linking. This tech-
nique allows the formation of zero length carboxyl-amino
bonds between glutamate residues (E) or aspartate (D) resi-
dues that are in close proximity to either lysine (K) or arginine
(R) residues, either in diﬀerent proteins or in the same protein.
Proteins that are oligomeric will cross-link at the oligomeri-
sation interface and proteins that are intimately connected in
multi protein complexes will cross-link together. The result
B. Lambert, M. Buckle / FEBS Letters 580 (2006) 345–350 347of this will be to produce slower migrating complexes on SDS–
PAGE as shown in Fig. 2A. Cross-linking of GST alone pro-
duced no slower migrating bands. Even in the absence of the
cross-linking cocktail, there was slower migrating material
(Fig. 2A, lane a band 1) for NPM probably due to aggrega-
tion. However, the amount of slower migrating material in-
creased considerably after incubation with the cross-linking
cocktail and the band corresponding to NPM (Fig. 2A, band
3 lanes a and b) decreased with increasing incubation time with
the cross-linking cocktail and eventually disappeared after
5 min (Fig. 2A, band 3 lane c), all the protein now being in
band 1. The GST-p53 protein (Fig. 2A, band 2) produced veryFig. 2. Analysis of cross-linked and non-cross-linked samples after
treatment of NPM, GST-p53 and NPM–GST-p53 mixture by the
cross-linking reagents EDC/NHS. (A) 12% SDS/PAGE: NPM
(10 lM), NPM + GST-p53 (10 lM each) and GST-p53 (10 lM) were
incubated 60 min at 4 C in PBS saline buﬀer. Before addition of the
EDC/NHS cross-linking cocktail proteins were kept at 25 C for
15 min. Lane a: H2O was substituted for the EDC/NHS cocktail,
EDC/NHS cocktail was added to a ﬁnal concentration of 20 mM
(EDC) and 5 mM (NHS) for 2 min lane b and for 5 min lane c. (1)
Cross-linked slower migrating material, (2) GST-p53, (3) NPM.
Reactions were stopped by the addition of SDS/PAGE loading buﬀer
supplemented with ethanolamine (250 mM ﬁnal concentration). (*):
limit of the stacking gel. (B) Residual NPM and GST-p53 monomers
remaining after cross-linking. Bands corresponding to non-cross-
linked monomers were scanned and the intensity quantiﬁed using
ImageQuant software. Results were expressed as a pourcentage of
control monomer (monomer from non-EDC/NHS treated protein see
above). Histograms in black correspond to NPM and those in grey to
p53. (a) Protein alone. (b) Mixture of NPM and p53.little of the slower migrating material (Fig. 2A, lanes a, band 1)
but some degree of cross-linking occurred since the amount of
material in Fig. 2A, band 2 decreased with increasing time
of incubation with the cross-linking cocktail. The mixture of
NPM and GST-p53 also showed a greater decrease in the
amount of band 3 as would be expected were there an interac-
tion between NPM and GST-p53. We were unable to fully
cross-link all the p53 since the internal cross-linking of NPM
presumably competed for the reaction with GST-p53. The re-
sults in Fig. 2A suggest that there is indeed an intimate inter-
action between GST-p53 and NPM.
We consistently noted that the amount of NPM remaining
after a given time of cross-linking was reduced in the presence
of p53, even though the amount of p53 that was not cross-
linked remained the same (Fig. 2B).3.3. SELDI analysis of cross-linking of NPM to GST-p53
Following cross-linking, bands were excised from the gel and
subjected to in situ trypsin digestion as described in Section 2.
The resulting peptides were analysed using a SELDI mass
spectrometer and the results are shown in Fig. 3. The peptide
proﬁles for NPM and p53 allowed extensive coverage and
identiﬁcation of expected peptides present in both the non-
cross-linked and cross-linked samples (Fig. 3). The upper band
from Fig. 2A presumably containing the cross-linked material
should contain peptides deriving from GST-p53 and NPM and
since GST alone did not cross-link it is assumed that if cross-
linking has occurred between p53 and NPM then some of the
material in the slower migrating bands will result from cross-
links between p53 and NPM.
Peptide analysis of the slower migrating material (band 1 in
Fig. 2A) following cross-linking of NPM and p53 revealed a
number of peptides that arise from digestion of both p53
and NPM (Fig. 3) and two new peaks having m/z values of
3984 + H and 4132 + H (Fig. 3A) that were absent in NPM
or p53 alone or when NPM or p53 alone were independently
cross-linked (data not shown). These m/z values cannot be as-
cribed to either of the proteins alone nor to possible combina-
tions of homo oligomeric forms involving either NPM or p53.
Consequently these peaks arise from the formation of cross-
links between NPM and p53. An analysis of the masses of
these peaks with those expected for cleavage was undertaken;
looking for possible combinations of cleavage products be-
tween NPM and p53 that satisﬁed the assumption that one
of the peptides would contain an uncleaved R or K residue
which would in fact constitute the point of contact with a glu-
tamate in an associated peptide. All possible combinations
(also taking into account possible modiﬁcations such as the
oxidation of methionines, or the presence of a stable succinim-
idyl ester with an E or D residue) are shown in Table 2. Pro-
teolytic analysis of NPM alone produced many of the
expected peaks (62% of predicted single cleavages identiﬁed).
One of the expected cleavage products from NPM 252–260
(m/z of 932.0) corresponds to the sequence GPSSVEDIK. This
peak is absent in the digestion proﬁle of the putative cross-
linked NPM–GST-p53 as would be expected if this peptide
were to be involved in the cross-link with GST-p53 to form
the peptides giving m/z values of 3984+H and 4132+H. A sim-
ilar argument can be applied for p53. Tryptic digestion of p53
allowed identiﬁcation of 24% of the expected peaks. However,
peptides involved in the putative contact to give the 4132 m/z
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Fig. 3. Mass spectrogram obtained from a SELDI analysis of digests of cross-linked material separated from gels of the type shown in Fig. 2. A:
zoomed area of the spectrogram containing new peaks.
Table 2
Potential combinations that could account for the peptides arising from the EDC/NHS cross-linking of GST-p53 and NPM
p53 NPM Cross-linked peptide
From–to Sequence From–to Sequence Dalton
66–72 MPEAAPR 37–66 ADKDYHFKVDNDENEHQLSLRTVSLGAGAK 4132
175–181 RCPHHER 86–115 VTLATLKMSVQPTVSLGGFEITPPVVLRLK 4132
343–363 ELNEALELKDAQAGKEPGGSR 252–269 GPSSVEDIKAKMQASIEK 4132
249–273 RPILTIITLEDSSGNLLGRNSFEVR 207–218 SIRDTPAKNAQK 4132
175–196 RCPHHERCSDSDGLAPPQHLIR 249–262 TPKGPSSVEDIKAK 3984
175–196 RCPHHERCSDSDGLAPPQHLIR 206–218 KSIRDTPAKNAQK 3984
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(MH2+) 530.11 (MH+) corresponding to the sequence
ELNEALELK, and peptides involved in the putative contact
to give the 3984 m/z peak, i.e., 175–196 2525.84 (MH+) corre-
sponding to the sequence RCPHHERCSDSDGLAPPQHLIR
are also absent in the cross-link digestion.
Taken together these data strongly suggest that the peptides
listed in Table 3 are involved in the interface recognitiondomain between NPM and GST-p53. The region containing
the sequence from 249 to 269 in NPM lies within a domain be-
lieved to interact with a variety of other proteins (Fig. 4A and
[14,15,18,19]). p53 is characterised by diﬀerent functional do-
mains (see Fig. 4B). The two peptides identiﬁed on p53 lie in
two separate functional domains: one in the oligomerisation
domain (343–363) and the other in an exposed loop from
175 to 196 within the DNA binding domain.
Table 3
Likely candidates
p53 NPM Cross-linked peptide
From–to Sequence From–to Sequence Dalton
343–363 ELNEALELKDAQAGKEPGGSR 252–269 GPSSVEDIKAKMQASIEK 4132
175–196 RCPHHERCSDSDGLAPPQHLIR 249–262 TPKGPSSVEDIKAK 3984
This provides the same domain in NPM from 249–269 involved in the contacts. There are two domains in p53: the oligomerisation domain (343–363)
and the exposed loop (175–196). The K residues in NPM most likely interact with the E residues in p53.
Fig. 4. Schematic representation of proteins NPM, p53 and model for
p53–NPM interactions. (A) NPM protein: homo-oligomerisation
domain (residues 1–120), acidic domains (residues 120–133 and 160–
188); hetero-oligomerisation domain (188–257), nucleic acid binding
domain (257–294). Underlined region (residues 249–262) is the region
implicated in the interaction with p53. (B) p53 protein: N-terminal
domain (residues 1–93); DNA binding domain (residues 102–292);
tetramerisation domain (residues 323–356) containing a NES (residues
340–351) and a regulatory domain (residues 363–393). Underlined
regions (residues 175–196 and 343–363) are implicated in the interac-
tion with NPM. (C) Model of p53–NPM interaction: Two NPM
proteins interact with two diﬀerent domains of one p53 protein
through their C-terminal region (residues 249–262). The overall global
structure may be hexameric (NPM).
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contact two separate parts of p53. However, judging from the
apparent stoichiometry measured by SPR, i.e., of one p53 mol-
ecule interacting with one NPM dimer, perhaps diﬀerent parts
of the p53 molecule interact with the same region on separate
monomers of an NPM dimer. We illustrate this type of
arrangement in Fig. 4C. A prediction of this model is that it
would stabilise interactions between similar interfaces on the
NPM molecule (Fig. 4C) that favour dimerisation of NPM
molecules attached to a p53 molecule. This is consistent withthe observation here that the rate of disappearance of the band
due to NPM increased considerably in the presence of p53,
although there was no concomitant increase in the rate of dis-
appearance of the band corresponding to GST-p53. At the
same time the rate of appearance of slower migrating material
at the top of the gel increased when both GST-p53 and NPM
were present. Since the small amount of cross-linking of GST-
p53 alone did not change whether NPM was present or not,
this material can derive from cross-linked monomers of
NPM as well as NPM–GST-p53 complex. This model would
explain the increased kinetics of disappearance of NPM mono-
mer when the cross-linking is performed in presence of p53
(Fig. 2B). The active form of NPM has been reported to be
a hexamer [20]. Interaction with p53 could facilitate NPM hex-
amer formation.
At physiological temperatures, the N-terminal domain of
p53 is largely unfolded although the DNA binding and tetr-
amerisation domains are highly structured [21]. It might be
expected given the chaperone function of NPM, that the
unstructured N-terminal domain would be a target to interact
with NPM, as has been observed by Maigel et al. [12], How-
ever, neither the DNA binding domain nor the tetramerisa-
tion domain lie within the N-terminal domain. We analysed
NPM–p53 interactions at 25 C. At this temperature, p53 pro-
tein keeps its native conformation [21,22]. Recently, it has
been shown that Hsp90 regulates the stability and the DNA
binding ability of p53WT at physiological and heat shock tem-
peratures through its interaction with the DNA binding do-
main [21]. NPM is a protein induced by genotoxic stress
just like Hsp90 is induced by heat shock [21]. Thus NPM
may protect p53 from degradation by a similar mechanism.
Furthermore, NPM also interacts with a region of the oligo-
merisation domain which contains a nuclear export signal
(NES) sequence (residues 340–351). This region regulates
the nuclear export of p53 which is essential for its proteoso-
mal degradation [23]. It was proposed that active p53 would
remain in the nucleus because the NES would be masked un-
der the active tetrameric form but exposed in a dimeric or
monomeric form. Exposure of the NES to the ran-CRM1 ex-
port machinery would lead to removal of p53 to the cytosol.
Accordingly, a role for NPM would be to interact with and
protect the otherwise exposed NES when p53 was in a non-
tetrameric form thus maintaining a reservoir of p53 to enter
into equilibrium with the active tetrameric form of p53 in
the nucleus.
Finally, the studies here are conducted on non-modiﬁed re-
combinant proteins. In vivo both NPM and p53 undergo
extensive modiﬁcation (phosphorylation, acetylation, sumoy-
lation etc. [24–27]) which may be involved in regulation of
the basic model we propose here. This model predicts that
NPM stabilises certain conformers of p53 and thus inﬂuences
their DNA binding capacity.
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